Rationalising CE ratios and qualifying QALYs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.534, 2007-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QALYs and Carers

By Al-Janabi Hareth

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1015-1023

Adis International

Access to resources Recommend Favorite

The Value of Thinly Spread QALYs

By Mortimer Duncan

PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. : 845-853

Adis International

Access to resources Recommend Favorite

QALYs imperfect, but still the NICE choice

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Economics of Pharmacogenomics: Rethinking Beyond QALYs?

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 187-195

Bentham Science Publishers

Access to resources Recommend Favorite

Use of QALYs by UK NICE for IFN- decision inappropriate

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 284, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite